Drugs

Insys Therapeutics Receives FDA Orphan Drug Designation for Liposome Entrapped Paclitaxel as a Potential Treatment for Gastric Cancer

PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 12/09/14 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery ...

VANC Pharmaceuticals Announces Conditional Approval of Previously Announced Private Placement

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/08/14 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF), a pharmaceutical company focused ...

Parallel Comparison Analyses Confirm That Insys Therapeutics' Synthetic CBD Is Identical in Chemical Structure to Plant-Derived CBD

PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 12/04/14 -- Independent comparison analyses have found that cannabidiol (CBD) synthetically produced by Insys Therapeutics, Inc. (NASDAQ: INSY) is chemically identical ...

Proteostasis Therapeutics Announces Appointment of Dr. Po-Shun Lee as Vice President of Clinical Development

CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwired) -- 12/03/14 -- Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with orphan a ...

Global Blood Therapeutics to Present New Data Highlighting Therapeutic Potential of GBT440 in Sickle Cell Disease (SCD) at 2014 American Society of Hematology (ASH) Conference

SOUTH SAN FRANCISCO, CA: Groundbreaking Disease-Modifying Treatment for SCD Is Focus of Oral and Poster Presentations ...

Joseph Lobacki to Become Medivation's Chief Commercial Officer

SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 11/25/14 -- Medivation, Inc. (NASDAQ: MDVN) today announced that Joseph Lobacki will join the company as chief commercial officer on December 8, 2014. In this po ...

New PSA Reminds College Students That Vaccination Is the Best Form of Protection Against Dangerous Flu Virus

KING OF PRUSSIA, PA: College Population's Low Vaccination Rates, High-Touch Living Spaces Pose Increased Risk ...

New Federal Funding Enables CDRD and CDRD Ventures Inc. to Expand Support to Canadian Entrepreneurs

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/21/14 -- This morning at the BC Technology Industry Association, The Honourable James Moore, Minister of Industry announced that The Centre for Drug ...

Insys Therapeutics to Present at 26th Annual Piper Jaffray Healthcare Conference

PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 11/19/14 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery ...

Medifocus Inc.'s Form 20-F Registration Statement Becomes Effective Immediately

COLUMBIA, MD and TORONTO, ON: COLUMBIA, MD and TORONTO, ON -- (Marketwired) -- 11/19/14 -- (OTCQX: MDFZF) (TSX VENTURE: MFS) announced today that its Registration Statement on Form 20-F that was filed with the U.S. Securities and ...